Authors


Casey Seideman, MD

Latest:

Laparoendoscopic single-site surgery in urologic patients: What does the future hold?

In this article, we briefly review the literature suggesting LESS is safe and holds a potential advantage over conventional laparoscopy. We then describe our techniques and outcomes for performing an extirpative (nephrectomy) and reconstructive (pyeloplasty) LESS procedure.


Aditya Bagrodia, MD

Latest:

The evolving role of microRNAs in testicular cancer management

"This brief review captures the evolving role of miRNAs, focusing on their clinical relevance and implications as well as future directions for more effective targeted therapeutic interventions," write the authors.


Cheryl Guttman Krader, BS, Pharm

Latest:

Large retrospective study identifies racial disparity in surgical management for BPH

A logistic regression analysis controlling for other major comorbidities, patient age, insurance status, and type of medical therapy found that Black patients were almost 40% less likely than White patients to undergo surgery for BPH.


Louise Gagnon

Latest:

Is low-intensity surveillance feasible for patients with high-risk NMIBC?

The study compared regimens for patients with high-risk non–muscle invasive bladder cancer.


Tim Lytle

Latest:

AACU: Circumcision controversy could hike urologists' liability premiums

Controversies related to circumcision could lead to a rise in medical liability for urologists performing this procedure, writes the American Association of Clinical Urologists' Tim Lytle.


July Capko

Latest:

How to reward employees for a job well done

Here are some tips for developing an incentive plan that will keep your medical staff motivated.


Cheryl Guttman Krader, BS, Pharm

Latest:

Pre-visit BPH decision aid provides valuable insights and optimizes care

The research also showed that the decision aid was well-received by patients as both satisfaction of men who used the tool and their willingness to recommend their physician were very high.


Karen Nash

Latest:

What is your reaction to the new AMA president describing health care as being in crisis?

"The burden of preauthorization, reimbursements not keeping up with inflation, and consequently, our abilities to staff and maintain our offices and pay our employees at appropriate levels are also affecting our ability to care for patients," said urologist Ronald P. Kaufman Jr, MD.


Wayne Kuznar

Latest:

PSA disadvantages discussed with minority of men

A minority of patients are involved in shared decision-making about prostate cancer screening with PSA, but new strategies to incorporate shared decision-making into practice are being investigated.


Ja-Hong Kim, MD

Latest:

Majority of nocturia patients have nocturnal polyuria

Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.


Richard R. Kerr

Latest:

FDA approves 2 PARP inhibitors for certain men with prostate cancer

The FDA has approved 2 poly (ADP-ribose) polymerase (PARP) inhibitors for men with metastatic castration-resistant prostate cancer who have certain genetic mutations, marking the first approvals of this newer drug class in prostate cancer.


Neil Baum, MD

Latest:

UroLift vs. TURP: New gold standard for BPH?

In this video, Neil Baum, MD, compares UroLift with other BPH management strategies and also discusses his experience with the use of nitrous oxide as an effective sedative during in-office urologic procedures.


Virginia Martin, CPC, CHBC

Latest:

How to bill for a locum tenens during a transition period

There are different ways to go about billing for a locum tenens depending on your circumstances.


Adonis Hijaz, MD

Latest:

Opportunistic salpingectomy in female urologic surgery

Evidence suggests fallopian tube removal will lead to reduced ovarian cancer ­incidence.


Sam S. Chang, MD

Latest:

Cost considerations in the management of bladder cancer

"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.


Penny Allen

Latest:

Marijuana use prevalent among chronic prostatitis/chronic pelvic pain syndrome patients

With marijuana legalized for medical use in Canada since 2001 and now in 17 U.S. states and the District of Columbia, urology patients in pain have been turning to marijuana for relief.


Bob Gatty

Latest:

Report urges action on physician burnout

A new report by the National Academy of Medicine urges action by government, educational institutions, and health care organizations to address the causes of physician burnout, which is experienced by up to one-half of clinicians in the U.S. and threatens patient care.


Ray Painter, MD

Latest:

23 years of helping urologists play physicians’ Monopoly

I wanted to take this opportunity to say thank you to all who have read my “Coding and Reimbursement” and “Coding Q&A” articles for the past 23 years.


Mark Painter

Latest:

How to bill for telephone-only urology visits

"For telephone-only (audio only) visits, Medicare has officially stated that such a visit would be considered the same as an in-person visit, with a few qualifications," write Jonathan Rubenstein, MD, and Mark Painter.


Peter C. Albertsen, MD

Latest:

Prostate cancer study highlights complexity of ‘appropriate’ care

"Deciding what care is appropriate is already extraordinarily difficult but will be a growing problem for the next generation of physicians and society," writes Peter C. Albertsen, MD.


Kathryn Foxhall

Latest:

'Medical home' gaining traction, but at what cost?

The controversial concept of medical home calls for a team led by a physician, usually a primary care physician, to be paid extra to handle personalized coordination of a patient's care across the health care system, including acting as liaison with other providers.


Peter Langenstroer, MD, MS

Latest:

Renal AML: The role of laparoscopic cryoablation

Five-year recurrence and disease-free survival rates for laparoscopic cryoablation are equivalent to those of standard open surgical techniques.


Andrew A. Wagner, MD

Latest:

Prostate cancer treatments: Assessing effects on quality of life

The most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.


Martin G. Sanda, MD

Latest:

Prostate cancer treatments: Assessing effects on quality of life

The most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.


Howard M. Snyder, III, MD

Latest:

Treatment of VUR: The bar is raised, morbidity lowered

The treatment paradigm for vesicoureteral reflux has undergone a significant shift in recent years. Endoscopic surgery has provided an effective, minimally invasive option that is gradually eliminating the need for prolonged antibiotic use, monitoring with voiding cystourethrograms (VCUGs), and open surgery in children with most grades and forms of VUR.


Leonard G. Gomella, MD

Latest:

Active Surveillance in Muscle Invasive Bladder Cancer

Types of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.


John T. Wei, MD, MS

Latest:

Prostate biopsies: How well do they predict tumor location?

Although needle biopsies are being used for localization, the majority of prostate cancers are multifocal in nature and invisible on gray scale ultrasonography.


Steven A. Kaplan, MD

Latest:

How to restart your practice when the COVID-19 red light turns green

"In the current environment of coronavirus disease 2019 (COVID-19), it has become obvious that it won’t be business as usual when the economy restarts and social distancing restrictions are relaxed," write Steven A. Kaplan, MD, and Alexis E. Te, MD.


S. Duke Herrell, MD

Latest:

Endoscopic robotic platforms: What the future holds

This article highlights some of the emerging endoscopic robotic systems in urology.


Ben H. Chew, MD, MSc

Latest:

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.

© 2025 MJH Life Sciences

All rights reserved.